The Goldman Sachs Group Begins Coverage on Teladoc Health (NYSE:TDOC)

The Goldman Sachs Group began coverage on shares of Teladoc Health (NYSE:TDOC) in a research report released on Friday, MarketBeat reports. The brokerage issued a buy rating and a $14.00 price target on the health services provider’s stock.

A number of other brokerages have also commented on TDOC. Evercore ISI boosted their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. TD Cowen cut their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Oppenheimer lowered their price objective on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday, August 1st. DA Davidson cut their target price on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a research report on Thursday, August 1st. Finally, Jefferies Financial Group raised their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Fourteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $12.08.

Teladoc Health Stock Up 2.8 %

Shares of NYSE TDOC traded up $0.25 on Friday, hitting $9.21. The company had a trading volume of 11,492,153 shares, compared to its average volume of 5,534,646. The firm has a market capitalization of $1.59 billion, a P/E ratio of -1.59 and a beta of 0.90. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $22.54. The business has a 50 day moving average of $8.89 and a two-hundred day moving average of $9.41.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, equities research analysts forecast that Teladoc Health will post -1.19 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, COO Michael Willem Waters sold 4,218 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the sale, the chief operating officer now owns 78,309 shares of the company’s stock, valued at $560,692.44. This trade represents a 5.11 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Thomas Mckinley bought 4,000 shares of Teladoc Health stock in a transaction on Thursday, September 12th. The shares were purchased at an average cost of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now directly owns 39,077 shares in the company, valued at $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 20,051 shares of company stock worth $143,565 over the last ninety days. Company insiders own 0.95% of the company’s stock.

Institutional Trading of Teladoc Health

Several hedge funds have recently added to or reduced their stakes in the business. Signaturefd LLC grew its stake in shares of Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC bought a new position in Teladoc Health in the 2nd quarter valued at about $29,000. Blue Trust Inc. increased its stake in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after buying an additional 1,854 shares during the period. Doheny Asset Management CA bought a new stake in shares of Teladoc Health during the 2nd quarter worth about $46,000. Finally, SageView Advisory Group LLC acquired a new stake in shares of Teladoc Health in the 1st quarter worth approximately $48,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.